Nottingham, UK – Juniper Pharma Services has confirmed a line-up of industry experts to speak at its Paediatrics seminar; ‘A bitter pill to swallow: challenges and advances in the development of medicines for children.’
Taking place at the Nottingham Belfry Hotel, December 5-6, 2017, the seminar will provide an insight into the challenges, current opinions and ‘best practice’ in providing new medicines for children, through presentations from select experts in the paediatrics field.
“In recent years there have been major changes in the children’s medicines field. We will be addressing a host of issues throughout the seminar from the challenges of paediatric formulations, to biopharmaceutical performance and acceptability to children, microneedles and taste masking strategies as well as providnsight into paediatric drug development from a regulatory perspective.
“This will be a diverse event which will no doubt spark fascinating debates and offer valuable learning for everyone in attendance.”
Joining Dr Harris is an impressive list of speakers including representatives from Hovione, Colorcon, XenoGesis, leading educational institutes and prominent paediatrics experts such as Dr Jenny Walsh and Dr Klaus Rose.
Dr Hannah Batchelor, senior lecturer in pharmaceutics, drug formulation and delivery and director of research for pharmacy at the University of Birmingham, will be presenting on ‘Paediatric Biopharmaceutics Assessment’. Dr Aaron Courtenay, research fellow at Queen’s University Belfast, will also be discussing ‘Microneedles for Pain-free Injection.’
The agenda culminates with Dr Andrew Parker, head of project management at Juniper, guiding delegates through the SPaeDD-UK project. The project is a pan-industry and academia UK Innovate sponsored initiative which aims to better define and improve paediatric drug product development with respect to taste, acceptability and bioavailability.
Click here for further information and registration for this free event.